Markey Cancer Center (MCC) Administration provides efficient and effective administrative support to MCC's Director, Senior Leadership, Research Program Leaders, Shared Resource Facility (SRF) Directors and MCC members. The role of MCC Administration is to operationalize MCC's most critical research functions by fulfilling the following Specific Aims: 1) to accelerate the remarkable evolution of the MCC by leveraging resources and expanding MCC's infrastructure; 2) to promote the strategic planning and evaluation efforts of the MCC; and 3) to support the comprehensive basic science, clinical and cancer prevention activities of the MCC by fostering transdisciplinary and translational science. The MCC is a matrix cancer center with administrative staff providing support to 119 MCC members from 28 departments in 8 University of Kentucky colleges, with 28 faculty recruited in the last 4 years. MCC Administration leverages the expertise of its team members while operating in an innovative and efficient manner. New initiatives supported since the last grant cycle include: 1) implementing iLab Solutions (Agilent Technologies) across SRFs; 2) deploying $4.2M for new seed grant opportunities; 3) developing the ?Markey Women Strong? program in collaboration with the Markey Cancer Foundation to provide two $50,000 awards annually to female researchers in the MCC; 4) supporting a 38% increase of direct cancer-related research funding from $19.9M to $27.4M (corresponding 36% increase of total cancer-related research funding from $28.4M to $38.7M) between 2012-2017; 5) facilitating 7 successful CCSG supplement applications; 6) initiating development of 2 SRFs (Oncogenomics and Behavior and Community-Based Research); 7) providing full support for a Center of Biological Research Excellence application and funded award; 8) establishing the Department of Toxicology and Cancer Biology and the Center for Environmental and Systems Biochemistry to support research and educational efforts; 9) increasing the number of MCC Network sites from 8 in 2013 to 24 in 2017; 10) creating the MCC Research Network; 11) promoting communication throughout the MCC and catchment area with a new website and additional social media platforms; 12) fostering growth of the Clinical Research Office and creating the Clinical Research Enrollment and Development of Investigational Trials program to recognize faculty for clinical research efforts; 13) overseeing the expansion of space, including a dedicated Precision Medicine Center (PMC), a new inpatient floor with 63 additional beds and dedicated administrative space for the MCC Affiliate and Research networks; 14) planning utilization of 2 MCC research floors (50,329 sq. ft.) in the new Research Building 2, scheduled to open in 2018; 15) creating the MCC Community Outreach Program and establishing the annual Expressions of Courage event for cancer survivors; and 16) facilitating development and implementation of the 2017-2022 Strategic Plan.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA177558-08
Application #
9962309
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
8
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40526
Hubbard, W Brad; Harwood, Christopher L; Geisler, John G et al. (2018) Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice. J Neurosci Res 96:1677-1688
Alghamedy, Fatemah; Bopaiah, Jeevith; Jones, Derek et al. (2018) Incorporating Protein Dynamics Through Ensemble Docking in Machine Learning Models to Predict Drug Binding. AMIA Jt Summits Transl Sci Proc 2017:26-34
Wen, Yang-An; Xiong, Xiaopeng; Zaytseva, Yekaterina Y et al. (2018) Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis 9:265
Zhang, Hui; Fredericks, Tricia; Xiong, Gaofeng et al. (2018) Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. Breast Cancer Res 20:116
Zhong, Weixiong; Weiss, Heidi L; Jayswal, Rani D et al. (2018) Extracellular redox state shift: A novel approach to target prostate cancer invasion. Free Radic Biol Med 117:99-109
Liu, Xinan; Yu, Ye; Liu, Jinpeng et al. (2018) A novel data structure to support ultra-fast taxonomic classification of metagenomic sequences with k-mer signatures. Bioinformatics 34:171-178
Xiong, Gaofeng; Stewart, Rachel L; Chen, Jie et al. (2018) Collagen prolyl 4-hydroxylase 1 is essential for HIF-1? stabilization and TNBC chemoresistance. Nat Commun 9:4456
Jarrett, Stuart G; Carter, Katharine M; Bautista, Robert-Marlo et al. (2018) Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage. J Biol Chem 293:19025-19037
Al-Darraji, Ahmed; Haydar, Dalia; Chelvarajan, Lakshman et al. (2018) Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. PLoS One 13:e0200474
Choi, Yohan; Rosewell, Katherine L; Brännström, Mats et al. (2018) FOS, a Critical Downstream Mediator of PGR and EGF Signaling Necessary for Ovulatory Prostaglandins in the Human Ovary. J Clin Endocrinol Metab 103:4241-4252

Showing the most recent 10 out of 359 publications